Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.

FDA recall notice · announced March 19, 2025 · Aspen Biopharma Labs Pvt

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Reason for recall

CGMP Deviations

Notes

Distribution: Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
Lot/code information: Lot Numbers: HACUC0010722, exp. date Jun-2025 HACUC0010123, exp. date Dec-2025
Quantity: 5.1 kg
Status: Ongoing
Products in this recall event:
- Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping. (D-0262-2025)
- Alprostadil Container Description: Amber color bottle (D-0261-2025)
- Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping. (D-0260-2025)
- Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle (D-0264-2025)
- Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping. (D-0265-2025)
- Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping. (D-0263-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.